Drugs are for rich people; the poor get the scraps
Innovation by the drug industry has always taken a back seat to profits. Recently, Brazil has threatened to break Merck's patent on a much-needed AIDS drug if negotiations for a lower price render no results. The Wall Street Journal attacked Brazil in an editorial thusly: Drug innovation is a r